MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 81327 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 NIVOLUMAB 8798
1 PEMBROLIZUMAB 7873
2 ENZALUTAMIDE 5107
3 CARBOPLATIN 4603
4 EVEROLIMUS 4293
5 LETROZOLE 3364
6 IPILIMUMAB 3342
7 CAPECITABINE 3264
8 FULVESTRANT 3187
9 PACLITAXEL 3115
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFATINIB 1589 0.2588
1 STREPTOZOCIN 48 0.2400
2 GEFITINIB 1670 0.1966
3 PRALATREXATE 105 0.1820
4 CERITINIB 415 0.1817
5 RUCAPARIB 1165 0.1397
6 TISAGENLECLEUCEL 486 0.1363
7 RAMUCIRUMAB 699 0.1358
8 PEMBROLIZUMAB 7873 0.1249
9 FULVESTRANT 3187 0.1233
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION